Cargando…
Cell-surface central nervous system autoantibodies: Clinical relevance and emerging paradigms
The recent discovery of several potentially pathogenic autoantibodies has helped identify patients with clinically distinctive central nervous system diseases that appear to benefit from immunotherapy. The associated autoantibodies are directed against the extracellular domains of cell-surface–expre...
Autores principales: | Irani, Sarosh R, Gelfand, Jeffrey M, Al-Diwani, Adam, Vincent, Angela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4141019/ https://www.ncbi.nlm.nih.gov/pubmed/24930434 http://dx.doi.org/10.1002/ana.24200 |
Ejemplares similares
-
The autoantibody-mediated encephalitides: from clinical observations to molecular pathogenesis
por: Ramanathan, Sudarshini, et al.
Publicado: (2019) -
The clinical relevance of serum versus CSF NMDAR autoantibodies associated exclusively with psychiatric features: a systematic review and meta-analysis of individual patient data
por: Blackman, Graham, et al.
Publicado: (2022) -
Autoantibodies to central nervous system neuronal surface antigens: psychiatric symptoms and psychopharmacological implications
por: Pollak, T. A., et al.
Publicado: (2015) -
Disease-relevant autoantibodies in first episode schizophrenia
por: Zandi, Michael S., et al.
Publicado: (2010) -
Clinical and experimental studies of potentially pathogenic brain-directed autoantibodies: current knowledge and future directions
por: Varley, James, et al.
Publicado: (2014)